Abstract
From 1998 to 1991, an in-person baseline interview was administered to approximately 267,400 female textile workers in Shanghai, China. The cohort was followed until July 2000 for incident cancer cases. Incidence rate ratios (RR) for 12 types of cancers in users of oral contraceptives (OCs) were calculated using Cox Proportional Hazards analysis. There was a reduced risk of uterine corpus cancer for women who had ever used OCs (RR = 0.68, 95% CI = 0.45–1.04) and a trend of decreasing risk with increasing duration of use (p = 0.015). There was an increased risk of colon cancer in women who had used OCs for 10 years or more (RR = 1.56, 95% CI = 1.01–2.40) and an increased risk of rectal cancer in women who had ever used OCs (RR = 1.31, 95% CI = 0.98–1.75), with a trend of increasing risk with increasing duration of use (p = 0.017), but these associations may have been due to uncontrolled confounding by physical activity or other non-causal factors. No associations were observed between OCs and the risk of all cancers combined or for any of the nine other cancers. It is unlikely that the use of OCs has contributed to the temporal trends in cancer incidence in China in recent decades.
Similar content being viewed by others
References
Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F (2005) Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol 6(8):552–553. doi:10.1016/S1470-2045(05)70273-4
Coriaty Nelson Z, Ray RM, Gao DL, Thomas DB (2002) Risk factors for fibroadenoma in a cohort of female textile workers in Shanghai, China. Am J Epidemiol 156(7):599–605. doi:10.1093/aje/kwf094
Li H, Thomas DB (2000) Tubal ligation and risk of cervical cancer. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception 61(5):323–328. doi:10.1016/S0010-7824(00)00111-6
Rosenblatt KA, Gao DL, Ray RM, Rowland MR, Nelson ZC, Wernli KJ et al (2006) Induced abortions and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control 17(10):1275–1280. doi:10.1007/s10552-006-0067-x
Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL et al. (2002) Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 94(19):1445–1457
Ye Z, Gao DL, Qin Q, Ray RM, Thomas DB (2002) Breast cancer in relation to induced abortions in a cohort of Chinese women. Br J Cancer 87(9):977–981. doi:10.1038/sj.bjc.6600603
Parkin DM, Whelan S, Ferlay J, Teppo L, Thomas DB (eds) (2005) Cancer incidence in five continents, 1st edn. International Agency for Research on Cancer, Lyon
Breslow NE, Day NE (1987) The design and analysis of cohort studies. International Agency for Research on Cancer, Lyon
Rothman KJ, Greenland S (eds) (1998) Modern epidemiology, 2nd edn. Lippincott, Williams, and Wilkins, Philadelphia
Wernli KJ, Ray RM, Gao DL, De Roos AJ, Checkoway H, Thomas DB (2006) Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control 17(7):949–955. doi:10.1007/s10552-006-0034-6
Wu-Williams AH, Lee M, Whittemore AS, Gallagher RP, Jiao DA, Zheng S et al (1991) Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 51(9):2307–2311
Lacey JV, Colditz GA, Schottenfeld D (2006) Exogenous hormones. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 468–488
Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E (2001) Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 84(5):722–727. doi:10.1054/bjoc.2000.1622
Li W, Ray RM, Lampe JW, Lin MG, Gao DL, Wu C et al (2005) Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case–control study in Shanghai, China. Int J Cancer 115(6):981–993. doi:10.1002/ijc.20964
Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347(9017):1713–1727. doi:10.1016/S0140-6736(96)90806-5
Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE (1988) Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48(7):1949–1953
Wang QS, Ross RK, Yu MC, Ning JP, Henderson BE, Kimm HT (1992) A case–control study of breast cancer in Tianjin, China. Cancer Epidemiol Biomarkers Prev 1(6):435–439
Hsing AW, Rashid A, Devesa SS, Faumeni JF (2006) Biliary tract cancer. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 787–800
Yu MC, Yuan JM (2004) Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127(5):S72–S78. doi:10.1016/j.gastro.2004.09.018
Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE (2003) Hormonal factors and risk of lung cancer among women? Int J Epidemiol 32(2):263–271. doi:10.1093/ije/dyg064
Elliott AM, Hannaford PC (2006) Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners’ Oral Contraception Study. Contraception 73(4):331–335. doi:10.1016/j.contraception.2005.10.003
Vessey M, Painter R, Yeates D (2003) Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 362(9379):185–191. doi:10.1016/S0140-6736(03)13907-4
Wu-Williams AH, Dai XD, Blot W, Xu ZY, Sun XW, Xiao HP et al (1990) Lung cancer among women in north-east China. Br J Cancer 62(6):982–987
Hankinson SE, Danforth KM (2006) Ovarian cancer. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 1013–1026
Chen Y, Wu PC, Lang JH, Ge WJ, Hartge P, Brinton LA (1992) Risk factors for epithelial ovarian cancer in Beijing, China. Int J Epidemiol 21(1):23–29. doi:10.1093/ije/21.1.23
Shu XO, Brinton LA, Gao YT, Yuan JM (1989) Population-based case–control study of ovarian cancer in Shanghai. Cancer Res 49(13):3670–3674
Collaborative Group on Epidemiological Studies of Ovarian C, Beral V, Doll R, Hermon C, Peto R, Reeves G (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371(9609):303–314. doi:10.1016/S0140-6736(08)60167-1
Duell EJ, Holly EA (2005) Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol 161(8):741–747. doi:10.1093/aje/kwi104
Skinner HG, Michaud DS, Colditz GA, Giovannucci EL, Stampfer MJ, Willett WC et al (2003) Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev 12(5):433–438
Kreiger N, Lacroix J, Sloan M (2001) Hormonal factors and pancreatic cancer in women. Ann Epidemiol 11(8):563–567. doi:10.1016/S1047-2797(01)00219-8
Ji BT, Hatch MC, Chow WH, McLaughlin JK, Dai Q, Howe GR et al (1996) Anthropometric and reproductive factors and the risk of pancreatic cancer: a case–control study in Shanghai, China. Int J Cancer 66(4):432–437. doi:10.1002/(SICI)1097-0215(19960516)66:4<432::AID-IJC4>3.0.CO;2-X
Frise S, Kreiger N, Gallinger S, Tomlinson G, Cotterchio M (2006) Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the Canadian national enhanced cancer surveillance system. Ann Epidemiol 16(12):908–916. doi:10.1016/j.annepidem.2006.03.001
La Vecchia C, D’Avanzo B, Franceschi S, Negri E, Parazzini F, Decarli A (1994) Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer 59(6):761–764. doi:10.1002/ijc.2910590609
Preston-Martin S, Jin F, Duda MJ, Mack WJ (1993) A case–control study of thyroid cancer in women under age 55 in Shanghai (People’s Republic of China). Cancer Causes Control 4(5):431–440. doi:10.1007/BF00050862
Ron ESA (2006) Thyroid cancer. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 975–994
La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L et al (1999) A pooled analysis of case–control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10(2):157–166. doi:10.1023/A:1008832513932
Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF Jr et al (1999) Cancer incidence trends in urban shanghai, 1972–1994: an update. Int J Cancer 83(4):435–440. doi:10.1002/(SICI)1097-0215(19991112)83:4<435::AID-IJC1>3.0.CO;2-J
Acknowledgments
This work was supported by National Cancer Institute grants R03-CA80637, R01-CA46823, and R01-CA80180.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosenblatt, K.A., Gao, D.L., Ray, R.M. et al. Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control 20, 27–34 (2009). https://doi.org/10.1007/s10552-008-9213-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9213-y